 |
인쇄하기
취소
|
Sanofi-Aventis Korea launches sustained-release form of sodium valproate
Depakine Chronosphere (sodium vaproate), a new sustained-release sachet formulation for the treatment of epilepsy, has been launched from November 1, according to Sanofi-Aventis Korea.
Valproic acid is an oral anticonvulsant that is chemically unrelated to other anticonvulsants. Valproate sodium and divalproex sodium (a sustained-release form) are also commercially available and share the sa...
Valproic acid is an oral anticonvulsant that is chemically unrelated to other anticonvulsants. Valproate sodium and divalproex sodium (a sustained-release form) are also commercially available and share the sa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.